tradingkey.logo
tradingkey.logo
Suchen

Anika Therapeutics Inc

ANIK
Zur Watchlist hinzufügen
14.770USD
-0.370-2.44%
Handelsschluss 05/08, 16:00ETKurse um 15 Minuten verzögert
205.14MMarktkapitalisierung
VerlustKGV TTM

Anika Therapeutics Inc

14.770
-0.370-2.44%

mehr Informationen über Anika Therapeutics Inc Unternehmen

Anika Therapeutics, Inc. is engaged in the osteoarthritis pain management and regenerative solutions space focused on early intervention orthopedics. The Company is leveraging its core expertise in hyaluronic acid and implant solutions. It partners with clinicians to provide minimally invasive products that restore active living for people around the world. It is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. It is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.

Anika Therapeutics Inc Informationen

BörsenkürzelANIK
Name des UnternehmensAnika Therapeutics Inc
IPO-datumMay 16, 1985
CEOBlanchard (Cheryl Renee)
Anzahl der mitarbeiter288
WertpapierartOrdinary Share
GeschäftsjahresendeMay 16
Addresse32 Wiggins Ave
StadtBEDFORD
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl01730-2315
Telefon17814579000
Websitehttps://anika.com/
BörsenkürzelANIK
IPO-datumMay 16, 1985
CEOBlanchard (Cheryl Renee)

Führungskräfte von Anika Therapeutics Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Glenn R. Larsen, Ph.D.
Dr. Glenn R. Larsen, Ph.D.
Independent Director
Independent Director
50.26K
+28.18%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
39.84K
+35.55%
Mr. William R. (Bill) Jellison
Mr. William R. (Bill) Jellison
Independent Director
Independent Director
23.10K
+61.31%
Mr. Stephen D. (Steve) Griffin
Mr. Stephen D. (Steve) Griffin
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
22.36K
+59.44%
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Independent Director
Independent Director
20.40K
+69.42%
Dr. Cheryl Renee Blanchard, Ph.D.
Dr. Cheryl Renee Blanchard, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Susan L. N. Vogt
Ms. Susan L. N. Vogt
Independent Director
Independent Director
--
--
Mr. David B. Colleran, J.D.
Mr. David B. Colleran, J.D.
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
--
--
Mr. John Bell (Jack) Henneman, III
Mr. John Bell (Jack) Henneman, III
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Stephen O. Richard
Mr. Stephen O. Richard
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Glenn R. Larsen, Ph.D.
Dr. Glenn R. Larsen, Ph.D.
Independent Director
Independent Director
50.26K
+28.18%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
39.84K
+35.55%
Mr. William R. (Bill) Jellison
Mr. William R. (Bill) Jellison
Independent Director
Independent Director
23.10K
+61.31%
Mr. Stephen D. (Steve) Griffin
Mr. Stephen D. (Steve) Griffin
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
22.36K
+59.44%
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Independent Director
Independent Director
20.40K
+69.42%
Dr. Cheryl Renee Blanchard, Ph.D.
Dr. Cheryl Renee Blanchard, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

Umsatzaufteilung

Währung: USDAktualisiert: Mon, Apr 6
Währung: USDAktualisiert: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
OEM Channel
64.41M
57.09%
Commercial Channel
48.41M
42.91%
Nach RegionUSD
Name
Umsatz
Anteil
United States
70.06M
62.10%
Europe
22.21M
19.69%
Other
20.55M
18.21%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
OEM Channel
64.41M
57.09%
Commercial Channel
48.41M
42.91%

Aktionärsstatistik

Aktualisiert: Fri, May 8
Aktualisiert: Fri, May 8
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Caligan Partners, LP
10.79%
BlackRock Institutional Trust Company, N.A.
6.87%
The Vanguard Group, Inc.
5.82%
BlackRock Financial Management, Inc.
5.23%
Acadian Asset Management LLC
4.56%
Andere
66.73%
Aktionäre
Aktionäre
Anteil
Caligan Partners, LP
10.79%
BlackRock Institutional Trust Company, N.A.
6.87%
The Vanguard Group, Inc.
5.82%
BlackRock Financial Management, Inc.
5.23%
Acadian Asset Management LLC
4.56%
Andere
66.73%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
33.05%
Investment Advisor/Hedge Fund
29.77%
Hedge Fund
26.08%
Research Firm
7.36%
Individual Investor
5.93%
Pension Fund
0.80%
Venture Capital
0.17%
Bank and Trust
0.16%
Family Office
0.08%

Institutionelle Beteiligung

Aktualisiert: Wed, Apr 1
Aktualisiert: Wed, Apr 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q1
264
12.85M
96.55%
-1.61M
2025Q4
245
12.37M
97.19%
-666.00
2025Q3
267
12.37M
100.32%
-461.27K
2025Q2
295
12.88M
103.23%
-71.30K
2025Q1
297
12.95M
103.38%
-1.70M
2024Q4
298
12.83M
102.20%
-560.99K
2024Q3
297
13.48M
104.72%
-150.44K
2024Q2
301
13.64M
105.78%
+30.78K
2024Q1
301
13.61M
105.08%
-1.78M
2023Q4
304
13.45M
105.34%
+303.47K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Caligan Partners, LP
1.44M
10.71%
--
--
Jan 23, 2026
BlackRock Institutional Trust Company, N.A.
914.28K
6.82%
-6.31K
-0.69%
Dec 31, 2025
The Vanguard Group, Inc.
779.16K
5.81%
-1.50K
-0.19%
Dec 31, 2025
BlackRock Financial Management, Inc.
695.72K
5.19%
-80.71K
-10.40%
Dec 31, 2025
Acadian Asset Management LLC
606.54K
4.53%
-26.25K
-4.15%
Dec 31, 2025
Boothbay Fund Management, LLC
534.51K
3.99%
-5.13K
-0.95%
Dec 31, 2025
Morgan Stanley & Co. LLC
519.94K
3.88%
+372.34K
+252.25%
Dec 31, 2025
Renaissance Technologies LLC
515.72K
3.85%
-17.30K
-3.25%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
494.32K
3.69%
-106.84K
-17.77%
Dec 31, 2025
The Capital Management Corporation
500.46K
3.73%
-50.78K
-9.21%
Dec 31, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Invesco NASDAQ Future Gen 200 ETF
0.56%
Royce Quant Small-Cap Quality Value ETF
0.2%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.1%
iShares Micro-Cap ETF
0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.01%
Avantis US Small Cap Equity ETF
0.01%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
WisdomTree US SmallCap Fund
0.01%
iShares Russell 2000 Value ETF
0.01%
Mehr Anzeigen
Invesco NASDAQ Future Gen 200 ETF
Anteil0.56%
Royce Quant Small-Cap Quality Value ETF
Anteil0.2%
SPDR SSGA US Small Cap Low Volatility Index ETF
Anteil0.1%
iShares Micro-Cap ETF
Anteil0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.02%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Anteil0.01%
Avantis US Small Cap Equity ETF
Anteil0.01%
Invesco RAFI US 1500 Small-Mid ETF
Anteil0.01%
WisdomTree US SmallCap Fund
Anteil0.01%
iShares Russell 2000 Value ETF
Anteil0.01%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI